Latest filing published 07 Mar 2019 for Reata Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Edward Bass: trading record in brief
James Edward Bass discloses dealings in Reata Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 1 June 2016 to 5 March 2019, the count stands at 18 filings.
On the open market, the record shows 8 purchases worth €817k and 1 sale worth €518k. Purchases outweigh sales by €300k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2019 alone, the filings show no purchases and 1 sale.
In size, the median ticket on the buying side is €84k. 3 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 7 March 2019 with a transaction in Reata Pharmaceuticals Inc. The most recent open-market purchase was published on 21 December 2018, 2,880 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James Edward Bass
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,631 shares0Class A common stockSEC:0001209191-19-017820:0
- 5,852 shares@ US$100.2973.4% of flowClass A common stockSEC:0001209191-19-017820:1
- 888 shares@ US$52.125.8% of flowClass A common stockSEC:0001209191-18-063808:0Canonical exit: 20 Mar 2019 (T+90)
- 1,679 shares@ US$59.3311.2% of flowClass A common stockSEC:0001209191-18-059094:0Canonical exit: 14 Feb 2019 (T+90)
- 888 shares@ US$78.345.9% of flowClass A common stockSEC:0001209191-18-044017:0Canonical exit: 23 Oct 2018 (T+90)
- 15,322 shares0Class A common stockSEC:0001209191-17-061259:0
- 5,322 shares0Class A common stockSEC:0001209191-17-061259:1
- 3,888 shares@ US$24.025.9% of flowClass A common stockSEC:0001209191-17-061259:2Canonical exit: 13 Feb 2018 (T+90)
- 8,064 shares@ US$31.0015.9% of flowClass A common stockSEC:0001209191-17-046876:0Canonical exit: 30 Oct 2017 (T+90)
- 28,762 shares0Class A common stockSEC:0001209191-17-002556:0
- 38,447 shares0Class A common stockSEC:0001209191-17-002556:1
- 16,107 shares0Class A common stockSEC:0001209191-17-002556:2
- 5,000 shares@ US$21.767.7% of flowClass A common stockSEC:0001209191-16-155300:0Canonical exit: 14 Mar 2017 (T+90)
- 2,585 sharesClass A common stockSEC:0000899243-16-021418:1
- 3,455 sharesClass A common stockSEC:0000899243-16-021418:3
- 1,448 sharesClass A common stockSEC:0000899243-16-021418:4
- 5,000 shares@ US$13.284.4% of flowClass A common stockSEC:0000899243-16-021418:0Canonical exit: 30 Aug 2016 (T+90)
- 18,000 shares@ US$11.0013.3% of flowClass A common stockSEC:0000899243-16-021418:2Canonical exit: 30 Aug 2016 (T+90)
18 of 18 declarations
